Joerg Ahlgrimm

The Discovery Labs LLC, a part of MLP Ventures, is a provider of world-class CGMP manufacturing, turnkey laboratory solutions, critical materials, and office space that support therapeutic products and services to the biotechnology and pharmaceutical industry. The private company is based in King of Prussia, PA, and was founded by Brian J. O'Neill and Audrey E. Greenberg. The location in eastern PA is a prototype for a rollout of the Discovery Labs, providing big pharma, emerging life sciences, consumer, and technology companies flexible, end-to-end technical real estate and business infrastructure for the customer's entire lifecycle from discovery to delivery, including manufacturing capacity. The company enables its partners to accelerate the manufacturing of life-changing, life-saving therapies. The Discovery Labs is the first fully integrated environment that merges technology and life sciences under one roof to drive innovation. The company offers move-in ready spaces for turnkey cell and gene therapy laboratory, office, or manufacturing space experience. The Innovation Renaissance campus is split up into 14 office, pharma quality, FDA lab, and last-mile distribution buildings on 80 acres equipped with walking trails, fitness, a daycare, and brew pub for all tenants.

Part of SK, Inc., SK Pharmteco, Inc. is a customer-facing team that includes SK Biotek Ireland, Ampac Fine Chemicals, SK, Yposkesi, and Ampac Analytical. The company is based in Rancho Cordova, CA. The company creates market synergies in the CDMO space by combining complementary assets and expertise. SK Pharmteco provides high-quality services to its customers. Joerg Ahlgrimm has been the CEO of the company since 2022.

The Discovery Labs LLC, a part of MLP Ventures, is a provider of world-class CGMP manufacturing, turnkey laboratory solutions, critical materials, and office space that support therapeutic products and services to the biotechnology and pharmaceutical industry. The private company is based in King of Prussia, PA, and was founded by Brian J. O'Neill and Audrey E. Greenberg. The location in eastern PA is a prototype for a rollout of the Discovery Labs, providing big pharma, emerging life sciences, consumer, and technology companies flexible, end-to-end technical real estate and business infrastructure for the customer's entire lifecycle from discovery to delivery, including manufacturing capacity. The company enables its partners to accelerate the manufacturing of life-changing, life-saving therapies. The Discovery Labs is the first fully integrated environment that merges technology and life sciences under one roof to drive innovation. The company offers move-in ready spaces for turnkey cell and gene therapy laboratory, office, or manufacturing space experience. The Innovation Renaissance campus is split up into 14 office, pharma quality, FDA lab, and last-mile distribution buildings on 80 acres equipped with walking trails, fitness, a daycare, and brew pub for all tenants.

Part of SK, Inc., SK Pharmteco, Inc. is a customer-facing team that includes SK Biotek Ireland, Ampac Fine Chemicals, SK, Yposkesi, and Ampac Analytical. The company is based in Rancho Cordova, CA. The company creates market synergies in the CDMO space by combining complementary assets and expertise. SK Pharmteco provides high-quality services to its customers. Joerg Ahlgrimm has been the CEO of the company since 2022.